Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: GlobeNewswire
PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products – Integra® matrices, PriMatrix®, Cytal® and AmnioExcel® – utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra’s diverse portfolio spans multiple regulatory pathways positively impacted by these rulings—including the FDA-approved (PMA), world-renowned flagship Integra® Dermal Regeneration Template. “We applaud CMS for taking this unprecedented step to meaningfully modernize payment structures that prioritize both in
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare ConferenceGlobeNewswire
- Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
IART
Earnings
- 10/30/25 - Beat
IART
Sec Filings
- 11/6/25 - Form SCHEDULE
- 11/6/25 - Form 4
- 10/30/25 - Form 10-Q
- IART's page on the SEC website